# Opill

NDC: 0113-8101
Generic name: norgestrel
Labeler / Manufacturer: L. Perrigo Company
Product type: HUMAN OTC DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20240304

FDA application: NDA017031

## Active ingredients

- NORGESTREL: .075 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0113-8101"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0113-8101
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=69dfa2ac-6a7e-4587-929c-9acabd97973b